参附注射液对脓毒症患者免疫功能、炎症指标的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R631

基金项目:

广东省科技厅资助项目(20138021800238,2014A020221064);广东省中医药局科研课题(20162063)


Shenfu Injection Has Effect on Immune Function and Inflammatory Indexes in Patients with Sepsis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察参附注射液对脓毒症患者免疫功能、炎症指标及临床结局的影响。方法:将4 2例脓毒症患者随机分为治疗组和对照组各21例,对照组采用西医常规治疗,治疗组在西医常规治疗基础上给予参附注射液,疗程7天。比较2组治疗前、第3天及第7天的炎症指标[白细胞计数(WBC)、降钙素原(PCT)、C-反应蛋白(CRP)]、免疫指标[T淋巴细胞亚群:辅助性T淋巴细胞(CD4+)、抑制性T淋巴细胞(CD8+)、CD4+/CD8+比值、CD14+单核细胞/人白细胞DR抗原表达率(CD14+/HLADR)]、急性生理与慢性健康评分(APACHE Ⅱ评分),以及7天内死亡情况、多器官功能障碍综合征(MODS)发生率、住院天数,随访28天统计病死率。结果:治疗第3天,对照组CRP、PCT与治疗组WBC、CRP、PCT、APACHE Ⅱ评分均较治疗前降低,治疗组CD14+/HLA-DR较治疗前升高,并高于对照组,APACHE Ⅱ评分低于对照组,差异均有统计学意义(P<0.05)。治疗第7天,对照组WBC、CRP、PCT与治疗组WBC、CRP、PCT、APACHE Ⅱ评分均较治疗前降低,治疗组CD14+/HLA-DR较治疗前升高,CD4+/CD8+、CD14+/HLA-DR均高于对照组,APACHE Ⅱ评分低于对照组,差异均有统计学意义(P<0.05)。2组MODS发生率、7天死亡率、28天死亡率及住院时间比较,差异均无统计学意义(P>0.05);但治疗组较对照组而言,各指标均有下降趋势。结论:在西医常规治疗基础上使用参附注射液能改善脓毒症患者的免疫、炎症指标,有效调节脓毒症时机体的促炎/抗炎平衡,但对预后并无影响,其临床应用时机及指征尚值得深入探讨。

    Abstract:

    Objective:To observe the effect of Shenfu injection on immune indexes,inflammatory indexes and clinical outcomes in patients with sepsis.M e th o d s:Divided 42 cases of patients with sepsis into the treatment group and the control group randomly,21 cases in each group.The control group received the routine western medicine treatment, while the treatment group was additionally given Shenfu injection.The treatment for both groups lasted for 7 days.Compared inflammatory indexes[white blood cell count(WBC),procalcitonin(PCT),C-reactive protein(CRP)],and immune indexes[T lymphocyte subsets:helper T lymphocyte(CD4+), suppressor T lymphocyte(CD8+), CD4+/CD8+, CD14+monocytes/human leucocyte antigen-DR expression rate(CD14+/HLA-DR),scores of acute physiology and chronic health evaluation(APACHE II scores)]of the two groups before treatment,on the 3rdday and the 7thday.Compared the differences of the incidence of MODS and mortality and hospitalization days within 7 days,and statistically analyzed the mortality rate on the 28thday of follow-up.R e s u lts:On the 3rdday of treatment,the levels of CRP and PCT in the control group and the levels of WBC,CRP,PCT and APACHE II scores in the treatment group were all lower than those before treatment,CD14+/HLA-DR in the treatment group was higher than that before treatment and in the control group,and APACHE II scores were lower than those in the control group,differences being significant(P < 0.05).On the 7thday of treatment,the levels of WBC,CRP and PCT in the control group and the levels of WBC,CRP,PCT and APACHE II scores in the treatment group were all lower than those before treatment, CD14+/HLA-DR in the treatment group was higher than that before trentment.CD4+/CD8+,CD14+/HLA-DR in the treatment group were higher than those in the control group,and APACHE II scores were lower than those in the control group,differences being significant(P<0.05).There were no significant differences in the incidence of MODS,mortality rate within 7 days,mortality rate within 28 days and length of hospitalization between the two groups(P<0.05);but comparing with those in the control group,each index in the treatment group showed a downtrend relatively.Conclusion:The application of Shenfu injection based on the routine western medicine treatment can improve the immune and inflammatory indexes in patients with sepsis,effectively regulate the proinflammatory or anti-inflammatory balance of body with sepsis,but it has no effect on prognosis,and its clinical application timing and indications are worth further discussing.

    参考文献
    相似文献
    引证文献
引用本文

奚小土,朱满刚,刘云涛,李俊.参附注射液对脓毒症患者免疫功能、炎症指标的影响[J].新中医,2018,50(6):72-76

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-06-05
  • 出版日期: